Next-generation approaches to mine human immunity and inform antibody functional selection

Next-generation approaches to mine human immunity and inform antibody functional selection

Tuesday, March 30, 2021 2:00 PM to 2:20 PM · 20 min. (Africa/Abidjan)
Antibodies
New technology in screening & analytics
Presentation

Information

  • Natively paired libraries enable linked sequence and functional analysis
  • Enhanced antiviral antibody screening enabled by yeast display against many targets, including SARS-CoV-2High-throughput data reveals new antibody signatures as markers of in vivo expansion

Brandon DeKosky, Assistant Professor, University of Kansas 

ENPICOMENPICOM is an innovative bioinformatics software engineering company delivering ground-breaking products and customized solutions to decode the immune system and improve human health. With a diverse team of over 25 professionals, we serve customers from all over the world, from academic research centers doing basic research related to the immune system to biotech and global pharmaceutical companies focusing on the discovery and development of novel immunotherapies and vaccines.  Leveraging a unique mix of biological knowledge, bioinformatics method development, and software engineering skills, we developed a world-class repertoire sequencing data analysis solution, the ImmunoGenomiX (IGX) Platform. IGX is an innovative platform to manage, store, analyze, visualize, and interpret immune repertoire sequencing data from T and B cell receptors.  The smart analysis and visualization methods are also offered as IGX-Service. In collaboration with DDL Diagnostic Laboratory, we deliver full immune repertoire sequencing and analysis service.

Log in